Pfizer Inc. (NYSE:PFE) is one of the best affordable healthcare stocks to buy now. Scotiabank analyst Louise Chen reiterated a Buy rating on Pfizer Inc. (NYSE:PFE) on December 17 and set a price target of $30.00. The same day, Bernstein analyst Courtney Breen reiterated a Hold rating on the stock, keeping the associated price target the same at$30.00. Pfizer’s (PFE) Pipeline and Dividend Yield Make it a Compelling Income Stock Pfizer Inc. (NYSE:PFE) also received a rating update from BofA analyst Jason ...